DK0727996T3 - Fendazolformuleringer - Google Patents

Fendazolformuleringer

Info

Publication number
DK0727996T3
DK0727996T3 DK95901776T DK95901776T DK0727996T3 DK 0727996 T3 DK0727996 T3 DK 0727996T3 DK 95901776 T DK95901776 T DK 95901776T DK 95901776 T DK95901776 T DK 95901776T DK 0727996 T3 DK0727996 T3 DK 0727996T3
Authority
DK
Denmark
Prior art keywords
fendazole
formulations
fenbendazole
standing
efficacious
Prior art date
Application number
DK95901776T
Other languages
English (en)
Inventor
Leslie E Kyle
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0727996T3 publication Critical patent/DK0727996T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lock And Its Accessories (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
DK95901776T 1993-11-10 1994-11-09 Fendazolformuleringer DK0727996T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/149,877 US5538989A (en) 1993-11-10 1993-11-10 Fenbendazole formulations
PCT/US1994/012712 WO1995013065A1 (en) 1993-11-10 1994-11-09 Fenbendazole formulations

Publications (1)

Publication Number Publication Date
DK0727996T3 true DK0727996T3 (da) 2002-11-18

Family

ID=22532170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95901776T DK0727996T3 (da) 1993-11-10 1994-11-09 Fendazolformuleringer

Country Status (14)

Country Link
US (1) US5538989A (da)
EP (1) EP0727996B1 (da)
JP (1) JP3523260B2 (da)
KR (1) KR960705563A (da)
AT (1) ATE221780T1 (da)
BR (1) BR9408023A (da)
CA (1) CA2176223C (da)
DE (1) DE69431162T2 (da)
DK (1) DK0727996T3 (da)
ES (1) ES2181763T3 (da)
MY (1) MY115429A (da)
PH (1) PH31320A (da)
PT (1) PT727996E (da)
WO (1) WO1995013065A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES950907A2 (en) * 1995-12-01 1996-02-21 Chanelle Chemicals Ltd "A process"
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
PT1214052E (pt) * 1999-09-03 2004-12-31 Janssen Pharmaceutica Nv Formulacao veterinaria para a administracao de um medicamento insoluvel em agua a um animal visado, atraves de um sistema de distribuicao de agua
GB0105358D0 (en) * 2001-03-03 2001-04-18 Fluid Technologies Ltd Absorbent materials
US7396819B2 (en) 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7582612B2 (en) * 2004-03-12 2009-09-01 Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2005099692A1 (en) * 2004-04-07 2005-10-27 Intervet International B.V Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
KR101403135B1 (ko) 2006-06-14 2014-06-19 인터벳 인터내셔널 비.브이. 벤지미다졸 카르바메이트 및 폴리솔베이트를 포함하는 현탁물
EP2409683A1 (en) 2010-07-06 2012-01-25 KRKA, D.D., Novo Mesto Stable aqueous formulations comprising poorly water soluble active ingredients
MX344235B (es) * 2010-08-24 2016-12-07 Otsuka Pharmaceutical Co Ltd * Suspension y composicion en torta que contiene un derivado de carbostirilo y aceite de silicona y/o un derivado de aceite de silicona.
US10137111B2 (en) * 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
CN106727304B (zh) * 2017-04-06 2019-09-03 江西博莱大药厂有限公司 一种芬苯达唑混悬剂及其制备方法
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
WO2024026463A1 (en) * 2022-07-28 2024-02-01 Happy Healing Inc. Composition for nasal delivery of an active compound
CN116602964B (zh) * 2023-07-18 2023-09-22 山东国邦药业有限公司 一种芬苯达唑粉及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE684059A (da) * 1965-07-15 1967-01-13
BE793358A (fr) * 1971-12-27 1973-06-27 Hoechst Ag Nouveaux derives de 2-carbalcoxy-amino-benzimidazole presentantune activite anthelmintique et leur procede de preparation
US3897559A (en) * 1972-07-06 1975-07-29 Lilly Co Eli Anthelmintic phenylhydrazones
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
US4197307A (en) * 1977-04-12 1980-04-08 Ciba-Geigy Corporation 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
EP0090368B1 (en) * 1982-03-30 1987-09-02 Hoechst Uk Limited Anthelmintic preparations

Also Published As

Publication number Publication date
CA2176223C (en) 2003-02-11
MY115429A (en) 2003-06-30
US5538989A (en) 1996-07-23
EP0727996A1 (en) 1996-08-28
DE69431162T2 (de) 2002-12-12
PT727996E (pt) 2002-11-29
EP0727996B1 (en) 2002-08-07
WO1995013065A1 (en) 1995-05-18
PH31320A (en) 1998-07-06
KR960705563A (ko) 1996-11-08
DE69431162D1 (en) 2002-09-12
ES2181763T3 (es) 2003-03-01
JPH09506086A (ja) 1997-06-17
ATE221780T1 (de) 2002-08-15
EP0727996A4 (en) 1996-11-06
BR9408023A (pt) 1996-12-10
CA2176223A1 (en) 1995-05-18
JP3523260B2 (ja) 2004-04-26

Similar Documents

Publication Publication Date Title
DK0781551T3 (da) Retinoid-formuleringer i porøse mikrosfærer til nedsat irritation og forbedret stabilitet
ATE221780T1 (de) Fenbendazolformulierungen
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
YU47204B (sh) Derivati didehidro-vitamina d3
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
NO970051L (no) Vandige risperidon formuleringer
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
AU532114B2 (en) Salts of n-substituted-2-pyrrolidone-4-carboxylic acids
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
FI945081A (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
GR1001511B (el) Στεροειδείς συν?έσεις.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
ES2062145T3 (es) 1,8-naftiridinas substituidas.
NO941097L (no) Hudregenererende kosmetisk preparat
FI910112A (fi) Preparat foer lokalt bruk.
ATE195055T1 (de) Insektizide zusammensetzung die diatomeenerde und siliziumdioxid enthalten